The Post-REMS Long-Acting Psychiatric Revolution: How Subcutaneous Copolymer Delivery Unlocks Olanzapine Outpatient Economics
Dr. Dereck Mush, MD, MBAMental Health
Digital therapeutics, platforms and evidence in behavioural health: what works, what is regulated, and what is just an app.
Dr. Dereck Mush, MD, MBA
The Digital Health Valuation Reset: How Sword Health's Acquisition of Headspace Redefines Enterprise Whole-Person Care
Dr. Dereck Mush, MD, MBA
Medicare finally pays for prescription digital therapeutics, and the test begins
Dr. Dereck Mush, MD, MBAThe HealthTech Signal
The FDA asked hard questions about AI therapy chatbots. It has not yet answered them
The FDA asked hard questions about AI therapy chatbots. It has not yet answered them
Dr. Dereck Mush, MD, MBA
